Varenicline alone or with nicotine e-cigarettes for smoking cessation in people with mental illness and drug and/or alcohol dependence.

Phase 3

• Conditions: Smoking; Mental illness; Drug and alcohol dependence; Mental Health - Addiction; Mental Health - Other mental health disorders

• Registration Number: ACTRN12616001355460
• Lead Sponsor: The University of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-09-29
• Study Completion: 2019-03-15
• Last Update Posted: 28 June 2021

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

*currently live in the Auckland region
*are registered clients with Community Mental Health Services or Community Alcohol and Drug Services
*smoke cigarettes daily
*want to quit smoking
*are at least 18 years of age
*are able to provide written informed consent
*have access to a telephone (mobile and/or landline)
*are prepared to use varenicline alone or with e-cigarettes
*have tried to quit at least twice before with nicotine replacement therapy (NRT), and thus are eligible for special authority varenicline

Exclusion Criteria

*are pregnant or breastfeeding.
*are current users of other smoking cessation medications.
*are enrolled in a smoking cessation programme or another cessation research study.
*have used an e-cigarette for more than one week in the last year for smoking cessation.
*have contraindications for varenicline or nicotine e-cigarettes.
*another person in their household is already in the trial.

Study & Design

• Study Type: Interventional
• Study Design: Not specified